Original ArticleComparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13N-NH3 PET/CT
Introduction
Left ventricular mechanical dyssynchrony (LVMD) is defined as the differences in the timing of onset of contraction between the different myocardial segments and it may have prognostic value for risk stratification.1,2 LVMD by phase analysis of gated myocardial perfusion imaging (MPI) has emerged as a robust, automated, and reproducible technique to quantify mechanical dispersion.3 13N-ammonia (13N-NH3) may be used in PET/TC imaging and allows quantification of coronary flow reserve (CFR), myocardial blood flow (MBF) LV perfusion, wall motion, LV function and LVMD in patients with Coronary artery disease (CAD). Previous studies4, 5, 6 with different radiotracers such as Rubidium-82 and 99mTc-sestamibi, demonstrated that stress-induced ischemia causes dyssynchronous contraction in the ischemic region, leading to worsening of LVMD, but no previous study has examined the use of 13N-NH3. The aim of this study was to evaluate the relationship between perfusion pattern and stress-induced changes in LVMD using 13N-NH3 PET/CT after regadenoson stress and at rest.
Section snippets
PET/CT Imaging and Interpretation
Patients were in fasting state for stress studies. Maximal vasodilatation was obtained after I.V. injection of 400 mg of regadenoson over 10 seconds in the right antecubital vein followed by a bolus administration of a standard dose of 370 MBq of 13NH3 40 seconds after the end of regadenoson injection. The PET studies were acquired in 3D and list mode for 10 minutes starting acquisition immediately before 13NH3 injection by a discovery PET/CT 690 (GE Healthcare, Milwaukee, h Wisconsin, USA). A
Results
The demographics are in Table 1. Non significant differences were observed between ischemic and non-ischemic groups except of sex and history of diabetes. The LVMD parameters are in Table 2. The LVMD parameters (PSD and PHB) were not significant differences between stress and rest in each group. All LVMD parameters were higher in the ischemic patients compared to non- ischemic ones, but only PSD post- stress—ΔPSD—and PHB post stress were statistically significant. The correlation matrix between
Discussion
Intraventricular dyssynchrony reflects inhomogeneous timing of contraction of different myocardial segments, caused by disturbed myocyte stimulation or impaired contractility.8,9 It is helpful to recognize that even structurally normal hearts exhibit some degree of non-uniformity in contraction due to its complex spatial and geometric architecture. Contraction movements depend on the complex distribution of myocardial fibers within the epicardial and endocardial regions as they are oriented
New Knowledge Gained
13N-NH3 PET/TC represent a reliable method for estimating myocardial dyssynchrony parameters. The presence of ischemia is confirmed by a non-synchronous contraction of myocardial tissue and a decrease of myocardial blood flow, parameters evaluated after pharmacological stress test conducted with the use of regadenoson.
Funding
Open access funding provided by Università degli Studi di Brescia within the CRUI-CARE Agreement.
Disclosure
The Authors do not have any conflict of interest to declare.
Ethical standards
This human study has been approved by the institutional ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent
All persons gave their informed consent prior to their inclusion in the study.
References (19)
Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications
J Amer Coll Cardiol
(2008)- et al.
SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony
J Nucl Cardiol
(2011) Left ventricular dyssynchrony assessment by phase analysis from gated PET-FDG scans
J Nucl Cardiol
(2011)Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging
J Am Coll Cardiol
(1999)- et al.
Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial
J Nucl Cardiol
(2007) - et al.
Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching
JACC Cardiovasc Imaging
(2012) - et al.
The prognostic value of regadenoson myocardial perfusion imaging
J Nucl Cardiol
(2015) - et al.
Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging
J Nucl Cardiol
(2015) - et al.
Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients
J Nucl Cardiol
(2016)
Cited by (0)
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.